Tom Krzeminski continues to garner media attention following his arrival at Michelman Robinson, with his addition to the firm now featured by several outlets, including Commercial Dispute Resolution. That publication highlights Tom’s more than 25 years of experience as a first-chair trial lawyer handling sophisticated commercial, patent, trade secret, and Hatch-Waxman litigation, as well as his work in Section 337 investigations before the U.S. International Trade Commission and FDA-related regulatory matters. We’re thrilled to have Tom at MR and look forward to the impact he’s sure to have on our clients and litigation team.
